HUM vs IVF · P/E 39, rev $117.76B vs rev $6.8M
Humana Inc (HUM) versus INVO Fertility, Inc. (IVF) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
INVO Fertility, Inc. (IVF) is a medical devices company listed on US.
Latest reported HUM revenue for 2024-12-31 was $117.76B. Net income was $1.21B. Revenue was up 10.7% from 2023-12-31 to 2024-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported IVF revenue for 2025-12-31 was $6.8M. Net income was -$23.3M. Revenue was up 4.7% from 2024-12-31 to 2025-12-31. IVF currently screens at market cap $2.8M.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. IVF currently screens at market cap $2.8M.
Not investment advice. Open the HUM and IVF stock pages for the full models.
Not investment advice.